Covishield

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

India gives conditional market nod for Covishield and Covaxin

People will be able to buy Covishield and Covaxin from hospitals and clinics and the vaccination data have to be updated on Co-Win

A woman reacts as she receives a dose of the COVISHIELD vaccine, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, in an alley at a slum area in Ahmedabad, India, September 28, 2021. REUTERS/Amit Dave
South Asia

India rules out reducing gap between Covishield doses

Serum sends 10 lakh Covishield doses after 7-month halt
Covid-19 in Bangladesh

Serum sends 10 lakh Covishield doses after 7-month halt

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

UK recognises Covishield jab after India outcry

Contact nearby centres soon for 2nd dose of AstraZeneca: DGHS 
Bangladesh

Contact nearby centres soon for 2nd dose of AstraZeneca: DGHS 

The United States had in February invoked the Defense Production Act, which gives the power to control the distribution of products, to curb the export of raw materials critical for vaccine production.(Representational photo)
Coronavirus chronicle

WHO flags fake Covishield jabs in India, Africa

The study found that immunisation with a combination of an adenovirus vector platform-based vaccine followed by an inactivated whole virus vaccine was not only safe but also elicited better immunogenicity. Photo: UNB
Coronavirus chronicle

Better immune response from mixing Covaxin, Covishield, says ICMR study

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

'Covid recovered people with Covishield jabs safer against Delta variant': Study

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio
Coronavirus chronicle

Some European countries to allow travellers from India inoculated with Covishield

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio
Coronavirus chronicle

Covishield okayed by 7 EU Nations, Switzerland, Iceland

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU
Coronavirus chronicle

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

A man displays a vial AstraZeneca's COVISHIELD vaccine as the country receives its first batch of coronavirus disease (Covid-19) vaccines under COVAX scheme, in Accra, Ghana February 24, 2021. Photo: Reuters
Coronavirus chronicle

African Union wants Covishield approved for EU Covid-19 certificate

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo
Coronavirus chronicle

SII seeks EU travel approval for its Covishield vaccine